WEST PHARMACEUTICAL SERVICES, INC. Accumulated Other Comprehensive Income
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Accumulated Other Comprehensive Income of -$140.40 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-07-23
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$140.40M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$125.20M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$105.50M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$102.30M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$140.40M 10-Q · filed 2026-07-23 |
| 2026-03-31 | -$125.20M 10-Q · filed 2026-04-23 |
| 2025-12-31 | -$105.50M 10-Q · filed 2026-07-23 |
| 2025-09-30 | -$102.30M 10-Q · filed 2025-10-23 |
| 2025-06-30 | -$88.70M 10-Q · filed 2025-07-24 |
| 2025-03-31 | -$205.50M 10-Q · filed 2025-04-24 |
| 2024-12-31 | -$258.10M 10-K · filed 2026-02-17 |
| 2024-09-30 | -$136.30M 10-Q · filed 2024-10-24 |
| 2024-06-30 | -$216.90M 10-Q · filed 2024-07-25 |
| 2024-03-31 | -$192.30M 10-Q · filed 2024-04-25 |
| 2023-12-31 | -$143.80M 10-K · filed 2025-02-18 |
| 2023-09-30 | -$223.00M 10-Q · filed 2023-10-26 |
| 2023-06-30 | -$183.50M 10-Q · filed 2023-07-27 |
| 2023-03-31 | -$168.40M 10-Q · filed 2023-04-27 |
| 2022-12-31 | -$183.00M 10-K · filed 2024-02-20 |
| 2022-09-30 | -$308.50M 10-Q · filed 2022-10-27 |
| 2022-06-30 | -$245.90M 10-Q · filed 2022-07-28 |
| 2022-03-31 | -$182.40M 10-Q · filed 2022-04-28 |
| 2021-12-31 | -$159.60M 10-K · filed 2023-02-21 |
| 2021-09-30 | -$155.70M 10-Q · filed 2021-10-28 |
| 2021-06-30 | -$133.20M 10-Q · filed 2021-07-30 |
| 2021-03-31 | -$140.20M 10-Q · filed 2021-04-30 |
| 2020-12-31 | -$110.60M 10-K · filed 2022-02-22 |
| 2020-09-30 | -$159.50M 10-Q · filed 2020-10-23 |
| 2020-06-30 | -$187.80M 10-Q · filed 2020-07-24 |
| 2020-03-31 | -$192.30M 10-Q · filed 2020-04-24 |
| 2019-12-31 | -$149.60M 10-K · filed 2021-02-23 |
| 2019-09-30 | -$170.40M 10-Q · filed 2019-10-29 |
| 2019-06-30 | -$152.20M 10-Q · filed 2019-07-29 |
| 2019-03-31 | -$153.40M 10-Q · filed 2019-05-08 |
| 2018-12-31 | -$154.20M 10-K · filed 2020-02-24 |
| 2018-09-30 | -$153.80M 10-Q · filed 2018-10-30 |
| 2018-06-30 | -$143.70M 10-Q · filed 2018-07-31 |
| 2018-03-31 | -$95.80M 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$117.30M 10-K · filed 2020-02-24 |
| 2017-09-30 | -$130.60M 10-Q · filed 2017-10-31 |
| 2017-06-30 | -$151.80M 10-Q · filed 2017-08-01 |
| 2017-03-31 | -$179.00M 10-Q · filed 2017-05-05 |
| 2016-12-31 | -$186.80M 10-K · filed 2019-02-28 |
| 2016-09-30 | -$143.80M 10-Q · filed 2016-10-31 |
| 2016-06-30 | -$150.30M 10-Q · filed 2016-08-01 |
| 2016-03-31 | -$148.00M 10-Q · filed 2016-05-06 |
| 2015-12-31 | -$162.60M 10-K · filed 2018-02-26 |
| 2015-09-30 | -$154.40M 10-Q · filed 2015-11-02 |
| 2015-06-30 | -$160.20M 10-Q · filed 2015-08-03 |
| 2015-03-31 | -$170.30M 10-Q · filed 2015-05-06 |
| 2014-12-31 | -$119.20M 10-K · filed 2017-02-28 |
| 2014-09-30 | -$71.30M 10-Q · filed 2014-11-03 |
| 2014-06-30 | -$34.70M 10-Q · filed 2014-08-01 |
| 2014-03-31 | -$33.80M 10-Q · filed 2014-05-08 |
| 2013-12-31 | -$32.40M 10-K · filed 2016-02-26 |
| 2013-09-30 | -$69.50M 10-Q · filed 2013-11-04 |
| 2013-06-30 | -$91.40M 10-Q · filed 2013-08-05 |
| 2013-03-31 | -$92.50M 10-Q · filed 2013-05-06 |
| 2012-12-31 | -$75.90M 10-K · filed 2015-02-25 |
| 2011-12-31 | -$71.50M 10-K · filed 2013-02-27 |
| 2010-12-31 | -$31.30M 10-K/A · filed 2012-03-01 |
| 2009-12-31 | -$19.70M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |